Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fresenius Kabi Pharmaceuticals Holding, Inc., announced that it has filed its Form 10–Q with the Securities and Exchange Commission. Fresenius Kabi Pharmaceuticals Holding, Inc., acquired APP Pharmaceuticals, Inc., on September 2008. The Form 10–Q details the Company's unaudited financial statements for the quarter and six months ending June 2009.

Today in Financial Reports...keeping you current

VA Re-Ups with QuadraMed
HealthDataManagement, 12/18/09

Bristol-Myers Squibb Sets Exchange Ratio of 0.6313 for the Exchange Offer
Bristol Myers-Squibb Company, 12/17/09

Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address